Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 51, 2013, Pages 20705-20710

  Kulkarni, Smita ^a,b   Qi, Ying ^a,b   O'hUigin, Colm ^a   Pereyra, Florencia ^b   Ramsuran, Veron ^b   McLaren, Paul ^c   Fellay, Jacques ^c   Nelson, George ^a   Chen, Haoyan ^d,e   Liao, Wilson ^e   Bass, Sara ^a   Apps, Richard ^a,b   Gao, Xiaojiang ^a,b   Yuki, Yuko ^a,b   Lied, Alexandra ^b   Ganesan, Anuradha ^f   Hunt, Peter W ^g   Deeks, Steven G ^g   Wolinsky, Steven ^h   Walker, Bruce D ^b   Carrington, Mary ^a,b   more..

^a FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^f UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA C ANTIGEN; MICRORNA; MICRORNA 148A; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; BINDING SITE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; FEMALE; GENE INTERACTION; GENE LOCUS; GENETIC POLYMORPHISM; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDEL MUTATION; INFECTION RESISTANCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84890810681     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1312237110     Document Type: Article

References (29)

1. McCutcheon JA, Gumperz J, Smith KD, Lutz CT, Parham P (1995) Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J Exp Med 181(6):2085-2095.
2. Neefjes JJ, Ploegh HL (1988) Allele and locus-Specific differences in cell surface expression and the association of HLA class I heavy chain with beta 2-Microglobulin: Differential effects of inhibition of glycosylation on class I subunit association. Eur J Immunol 18(5):801-810.
3. Neisig A, Melief CJ, Neefjes J (1998) Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J Immunol 160(1):171-179.
4. Setini A, et al. (1996) Distinctive features of the alpha 1-Domain alpha helix of HLA-C heavy chains free of beta 2-Microglobulin. Hum Immunol 46(2):69-81.
5. Snary D, Barnstable CJ, Bodmer WF, Crumpton MJ (1977) Molecular structure of human histocompatibility antigens: The HLA-C series. Eur J Immunol 7(8):580-585.
6. Schaefer MR, et al. (2008) A novel trafficking signal within the HLA-C cytoplasmic tail allows regulated expression upon differentiation of macrophages. J Immunol 180(12): 7804-7817.
7. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D (1998) HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391(6665):397-401.
8. Blais ME, et al. (2012) High frequency of HIV mutations associated with HLA-C suggests enhanced HLA-C-Restricted CTL selective pressure associated with an AIDS-Protective polymorphism. J Immunol 188(9):4663-4670.
9. Specht A, et al. (2010) Counteraction of HLA-C-Mediated immune control of HIV-1 by Nef. J Virol 84(14):7300-7311.
10. Apps R, et al. (2013) Influence of HLA-C expression level on HIV control. Science 340(6128):87-91.
11. Kulkarni S, et al. (2011) Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472(7344):495-498.
12. Iwai N, Naraba H (2005) Polymorphisms in human pre-MiRNAs. Biochem Biophys Res Commun 331(4):1439-1444.
13. Saunders MA, Liang H, LiWH (2007) Human polymorphismat microRNAs and microRNA target sites. Proc Natl Acad Sci USA 104(9):3300-3305.
14. Quach H, et al. (2009) Signatures of purifying and local positive selection in human miRNAs. Am J Hum Genet 84(3):316-327.
15. Takagi S, Nakajima M, Mohri T, Yokoi T (2008) Post-Transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J Biol Chem 283(15):9674-9680.
16. O'huigin C, et al. (2011) The molecular origin and consequences of escape from miRNA regulation by HLA-C alleles. Am J Hum Genet 89(3):424-431.
17. Dalmasso C, et al.; ANRS Genome Wide Association 01 (2008) Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: The ANRS Genome Wide Association 01 study. PLoS ONE 3(12):e3907.
18. Fellay J, et al.; NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI) (2009) Common genetic variation and the control of HIV-1 in humans. PLoS Genet 5(12):e1000791.
19. Fellay J, et al. (2007) A whole-Genome association study of major determinants for host control of HIV-1. Science 317(5840):944-947.
20. Limou S, et al.; ANRS Genomic Group (2009) Genomewide association study of an AIDS-Nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 199(3):419-426.
21. Pelak K, et al.; Infectious Disease Clinical Research Program HIV Working Group; National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology (CHAVI) (2010) Host determinants of HIV-1 control in African Americans. J Infect Dis 201(8):1141-1149.
22. Pereyra F, et al.; International HIV Controllers Study (2010) The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330(6010): 1551-1557.
23. Corrah TW, et al. (2011) Reappraisal of the relationship between the HIV-1-Protective single-Nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expression. J Virol 85(7):3367-3374.
24. Phair J, et al. (1992) Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: The Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 5(5):490-496.
25. Emu B, et al. (2005) Phenotypic, functional, and kinetic parameters associated with apparent T-Cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J Virol 79(22):14169-14178.
26. Wellcome Trust Case Control C; Wellcome Trust Case Control Consortium (2007) Genome-Wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447(7145):661-678.
27. Duerr RH, et al. (2006) A genome-Wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314(5804):1461-1463.
28. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402-408.
29. R Core Team (2012) R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, Austria).